Showing 41-50 of 7019 results for "".
Gold's Standards: Nashville's Laser Guru on Best Practices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/gold-s-standards-nashville-s-laser-guru-on-best-practices/18867/When a third of your practice is dedicated to energy-based devices, it's important to find the best solutions for your patient flow. In this edition of Best Practices, Joel L. Cohen, MD talks to Michael H. Gold, MD about his approach to adoption and promotion of energy-based devices. Dr. Gold discusBONT-A Extends Fillers; Almirall to Acquire Thermi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-bont-a-extends-fillers-almirall-to-acquire-thermi/18648/In this edition of DermWireTV, a look at new data showing that injections with botulinum neurotoxin can extend the efficacy of hyaluronic acid fillers. The American Academy of Dermatology Association offers more response to the USPSTF draft recommendation on the benefits of skin exams for melanoma.Behind the Sunscreen Recall
https://practicaldermatology.com/topics/skin-cancer-photoprotection/behind-the-sunscreen-recall/23557/Use the latest media buzz as an excuse to educate.The Latest in Blistering Diseases
https://reachmd.com/programs/practical-dermatology/the-latest-in-blistering-diseases/33007/Kim B. Yancey, MD, a professor of dermatology at UT Southwestern Medical Center in Dallas, talks about current treatments and techniques for blistering diseases, focusing specifically autoimmune blistering diseases.Pipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigTo Be Shorr: Use Call Tracking Numbers to Measure Your Marketing ROI
https://practicaldermatology.com/topics/practice-management/to-be-shorr-use-call-tracking-numbers-to-measure-your-marketing-roi/18604/Tracking ROI on your marketing initiatives is an important but sometimes challenging undertaking. In this edition of "To Be Shorr," Mara Shorr, BS, CAC II-V shares tips for easily tracking your investments, including the use of call tracking numbers.Ask an Expert: Managing Pruritus in the Elderly
https://practicaldermatology.com/topics/psoriasis/askanexpertpt3/19032/From NewDermMD: Host Adam Friedman, MD gets experts to share their wisdom. In this edition, Timothy Berger, MD discuss the treatment of itchy skin (pruritus) in elderly patients.Ask an Expert: Diagnosing Pruritus in the Elderly
https://practicaldermatology.com/topics/psoriasis/ask-an-expert-diagnosing-pruritus-in-the-elderly/19033/From NewDermMD: Host Adam Friedman, MD gets experts to share their wisdom. In this edition, Timothy Berger, MD discuss the treatment of itchy skin (pruritus) in elderly patients.Ask an Expert: The Approach to Pruritus
https://practicaldermatology.com/topics/psoriasis/ask-an-expert-the-approach-to-pruritus/19034/From NewDermMD: Host Adam Friedman, MD gets experts to share their wisdom. In this edition, Timothy Berger, MD discuss the approach to itchy skin (pruritus), especially in elderly patients.DermwireTV — A big name is getting bigger; ICD-10 looms
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-a-big-name-is-getting-bigger-icd-10-looms/19163/In this premiere edition of DermWireTV, from the publishers of Practical Dermatology® magazine, we take a look at the latest acquisition by Valeant Pharmaceuticals, Inc., explore new data for Galderma's Mirvaso for rosacea, and get insights on the ICD-10 code set transition. #DermWire